Imbalance of the protease-antiprotease system against the background of chronic obstructive pulmonary disease in combination with ischemic heart disease

被引:0
|
作者
Kraidashenko, O. O. [1 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Dept Internal Dis 3, Zaporizhia, Ukraine
来源
PATHOLOGIA | 2023年 / 20卷 / 02期
关键词
ischemic heart disease; chronic obstructive pulmonary disease; matrix metalloproteinase 9; tissue inhibitor of metalloproteinases; fibrosis;
D O I
10.14739/2310-1237.2023.2.278133
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of the study: to evaluate the clinical value of the violation of the expression level of MMP-9 and TIMP against the background of chronic obstructive pulmonary disease (COPD) in combination with ischemic heart disease (IHD).Materials and methods. In accordance with the set goal of the study, 26 people with COPD + IHD and 22 practically healthy people were under observation. The average age of patients was 56.68 +/- 1.21 years; 76.92 % were men. In the control group, the average age was 54.37 +/- 1.84 years, 72.73 % were men. The object of the study was ischemic heart disease: angina pectoris. Research methods: external respiration function study, six minute walk test, determination of heart rate variability, the concentration of MMP-9 and TIMP in blood serum was determined by the method of solid-phase enzyme immunoassay.Results. The analysis of the level of expression of proteases and its inhibitor shows that patients with comorbid IHD on the background of COPD demonstrated 8.11 times higher activity of MMP-9 (p < 0.05) compared to a cohort of practically healthy people. Indicators of TIMP activity in patients with IHD on the background of COPD are 1.46 +/- 0.03 mu g/ml, which is statistically significantly lower by 53.21 % (p < 0.05) compared to healthy people (3.12 +/- 0.01 mu g/ml). The presence of reliable correlations between the MMP-9 level and the FEV1 indicator (r =-0.67, p < 0.05), the LF/HF parameter (r =-0.74, p < 0.05) indicates, that when the level of expression of MMP-9 is elevated, there is a more pronounced violation of the function of external respiration and a shift in the sympatho-parasympathetic balance in the direction of sympathetic activation and a decrease in vagal tone in heart rate modulation.The analysis of the meeting frequency with the analysis of conjugation tables showed that in persons in the upper quartile of MMP-9, prognostically negative parameters of the function of external breathing - an isolated decrease in the Tifno index (chi(2) = 5.2 at p = 0.03), as well as the expressiveness of shortness of breath - were recorded more often >= 6 points on the Borg scale when assessing exercise tolerance during the 6-minute walk test (chi(2)= 7.3 at p = 0.02).Conclusions. The obtained data demonstrate that patients with IHD on the background of COPD have a pronounced proteolytic imbalance and disruption of fibrotic processes compared to practically healthy individuals.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [31] Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management
    Campo, Gianluca
    Pavasini, Rita
    Malagu, Michele
    Mascetti, Susanna
    Biscaglia, Simone
    Ceconi, Claudio
    Papi, Alberto
    Contoli, Marco
    CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 147 - 157
  • [32] Features of clinical cours of chronic obstructive pulmonary disease and ischemic heart disease in case of comorbidity
    Didenko, Daria
    Rasputina, Lesya
    Mostovoy, Yuriy
    Cherepii, Nataliya
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Early diagnosis of ischemic heart disease in patients with chronic obstructive pulmonary diseases
    Paleev, NR
    Chereiskaya, NK
    Afonasyeva, IA
    Fedorova, SI
    TERAPEVTICHESKII ARKHIV, 1999, 71 (09) : 52 - 56
  • [34] PROTEASE INHIBITORS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    BARNETT, TB
    GOTTOVI, D
    JOHNSON, AM
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1975, 111 (05): : 587 - 593
  • [35] IMPAIRMENT OF THE PROTEASE-ANTIPROTEASE SYSTEM OF BRONCHIAL WASH-OUT IN PATIENTS WITH BRONCHIECTATIC DISEASE - APPROACHES TO ITS CORRECTION
    DUKOV, LG
    OGOL, AV
    TERAPEVTICHESKII ARKHIV, 1992, 64 (03) : 44 - 46
  • [36] Diastolic heart failure in patients with chronic obstructive pulmonary disease in combination with hypertension
    Melenevych, A. Anastasiya
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 208 - 209
  • [37] The Obesity Paradox in Chronic Heart Disease and Chronic Obstructive Pulmonary Disease
    Ravindran, Suganya Giri
    Saha, Debistuti
    Iqbal, Iffat
    Jhaveri, Sharan
    Avanthika, Chaithanya
    Naagendran, Mridula Sree
    Bethineedi, Lakshmi Deepak
    Santhosh, Tony
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [38] Acute decompensated heart failure and chronic obstructive pulmonary disease: A dangerous combination?
    Villacorta, Humberto
    Pereira, Carlos C.
    Miranda, Jacqueline
    Amador, Fernanda
    Pontes, Alvaro
    Resende, Plinio
    Petriz, Joao
    Albuquerque, Denilson
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S85 - S85
  • [39] Oxidant antioxidant imbalance in smokers and chronic obstructive pulmonary disease
    Rahman, I
    MacNee, W
    THORAX, 1996, 51 (04) : 348 - 350
  • [40] Systemic redox imbalance in stable chronic obstructive pulmonary disease
    Kopcinovic, Lara Milevoj
    Domijan, Ana-Marija
    Posavac, Ksenija
    Cepelak, Ivana
    Grubisic, Tihana Zanic
    Rumora, Lada
    BIOMARKERS, 2016, 21 (08) : 692 - 698